Surgery for Colorectal Liver Metastases
Authors:
- S.J. McNallySMS.J. McNally
- R.W. ParksRPR.W. Parks
- 17 September 2013
- journal article
- review article
- Published by S. Karger AG in Digestive Surgery
- Vol. 30 (4-6) , 337-347
Abstract
Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term cure. Appropriate patient selection for surgery and improvements in perioperative care have resulted in low morbidity and mortality rates, resulting in this being the therapy of choice for suitable patients. Modern management of colorectal liver metastases is multimodal incorporating open and laparoscopic surgery, ablative therapies such as radiofrequency ablation or microwave ablation and (neo)adjuvant chemotherapy. The majority of patients with hepatic metastases should be considered for resectional surgery, if all disease can be resected, as this offers the only opportunity for prolonged survival.Keywords
This publication has 101 references indexed in Scilit:
- Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodesJournal of Radiation Research, 2012
- Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatmentInternational Journal of Colorectal Disease, 2012
- Modern insights into hepatic arterial infusion for liver metastases from colorectal cancerEuropean Journal of Cancer, 2011
- Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialThe Lancet, 2011
- Anatomical Versus Nonanatomical Resection of Colorectal Liver Metastases: Is There a Difference in Surgical and Oncological Outcome?World Journal of Surgery, 2010
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialThe Lancet Oncology, 2010
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological FindingsJournal of Gastrointestinal Surgery, 2007
- Perihepatic Lymph Node Assessment in Patients Undergoing Partial Hepatectomy for MalignancyAnnals of Surgery, 2006
- Natural history of patients with untreated liver metastases from colorectal cancerThe American Journal of Surgery, 1981